The global NGS sample preparation market size is valued at 3.77 billion in 2022 and is predicted to reach 9.51 billion by the year 2031 at an 11.09% CAGR during the forecast period of 2023-3031.
Next-generation sequencing is one of the high-throughput DNA sequencing techniques that use the concept of massively parallel processing (NGS). Another name for it is "massively parallel sequencing." Different sequencing, chemical, and engineering setups are available for NGS platforms. NGS methods make it possible to determine RNA structures. NGS allowed for the rapid sequencing of the entire human genome in just one day. NGS technology has increased the precision and speed of genome sequencing.
Global market revenue growth is fueled by essential factors like growing acceptance for NGS in diagnostics due to lower costs of NGS products and the advent of low-cost sequencing methodologies. A few fundamental drivers driving the NGS Sample Preparation Market growth include the increasing prevalence of genetic disorders of infectious and chronic diseases and using NGS in cancer diagnoses and therapy.
NGS Sample Preparation Market Report Scope
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 3.77 billion |
|
Revenue forecast in 2031 |
USD 9.51 billion |
|
Growth rate CAGR |
CAGR of 11.09% from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
Workflow, Application, End-use |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Agilent Technologies, Bio-Rad Laboratories, Inc., Biomatters Ltd., Congenica Ltd, Eurofins Scientific, DNASTAR, F. Hoffmann-La Roche Ltd, Genomatix GmbH, Thermo Fisher Scientific and Foundation Medicine |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. Find purchase alternatives. |
Additionally, it is anticipated that factors like improved products for producing high-quality libraries with a high yield for effective sequencing would create more attractive prospects for top companies and accelerate market expansion in the upcoming years. However, the high cost of NGS and strict NGS-related restrictions in some countries may limit the growth of this worldwide sector.
Competitive Landscape
Key players in the NGS Sample Preparation Market are:
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Biomatters Ltd.
- Congenica Ltd
- Eurofins Scientific
- DNASTAR
- Hoffmann-La Roche Ltd
- Genomatix GmbH
- Thermo Fisher Scientific
- Foundation Medicine
Market Segmentation:
The NGS Sample Preparation Market is segmented on workflow, application and end-user. Based on workflow, the market is segmented into NGS library preparation kits, semi-automated library preparation, automated library preparation and clonal amplification. Based on the application, the market is segmented into oncology, clinical investigation, reproductive health, HLA typing/immune system monitoring, metagenomics, epidemiology & drug development, agrigenomics & forensics and consumer genomics.
Based on the end-user, the market is segmented into academic research, clinical research, hospitals & clinics, pharma & biotech entities and others. Based on workflow, the semi-automated library preparation category is accounted as a significant contributor to the NGS Sample Preparation Market .
The semi-automated library preparation category dominated the market in 2021. This is because the library preparation process uses both manual and automated methods. Automation is used in the combination approach to ligating SOLiD adaptors to the processed DNA, end repair, and purification processes. Gel purification and library amplification are two manual stages used in semi-automated library preparation techniques. In addition, the launch of automated library preparation solutions is predicted to fuel segment expansion. Labs will be able to work with fewer employees while still producing as much as possible due to advancements in automation that make it possible to execute complex library preparation methods with less manual labor.
The oncology category witnessed growth at a rapid rate.
The oncology category dominated the market in 2021 due to numerous participants working to construct oncology-focused panels. These panels state that there is a need for solutions for sample preparation. Companies are working together to produce oncology companion diagnostics solutions with the top biotechnology companies. Market participants are improving oncology companion diagnostics product options.
The North American NGS Sample Preparation Market holds a significant regional revenue share.
The North American NGS Sample Preparation Market is expected to register the highest market share in revenue shortly due to several variables, including the growing need for diagnostic tools for detecting health disparities, public knowledge of accessible technologies, the concentration of market players in the United States, and the expanding burden of infectious diseases and chronic diseases in the area.
The biotechnology and auxiliary markets in this region are also being driven by considerable R&D expenditure, a technologically advanced healthcare research framework, and the presence of significant companies. In addition, Asia Pacific is projected to grow rapidly in the global NGS Sample Preparation Market . The predicted growth tendency is attributed to changes in the legal framework, affordability trends, and technology advancements in the region's developing economies. Additionally, the existence of a diseased population boosts regional clinical trial-related activity, which raises the demand for NGS sample preparation.
